查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2038633

胃內球囊市場機會、成長要素、產業趨勢分析及2026-2035年預測。

Intragastric Balloon Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球胃內球囊市場價值為 7,750 萬美元，預計到 2035 年將達到 3.129 億美元，年複合成長率為 15.2%。

胃內球囊市場-IMG1

肥胖症盛行率上升、臨床意識增強、體重管理治療途徑增加以及肥胖相關療法的保險覆蓋範圍擴大，是推動市場成長的主要因素。醫療設備技術的不斷進步也提高了治療效果和病患的接受度。胃內球囊是一種微創、非手術的減重裝置，放置在胃內，透過產生飽足感來減少食物攝取。通常建議僅靠節食和運動無法達到理想效果的患者使用。這些裝置可透過內視鏡或膠囊形式植入，並在指定的治療期後取出。球囊設計的持續創新，包括可調節系統和可吞嚥膠囊技術，提高了安全性、舒適性和手術效率。數位健康工具和遠端患者監護的整合進一步加強了術後護理和患者依從性。專業肥胖管理診所的擴張也推動了該技術在整個醫療保健系統中的應用。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 7750萬美元
預測金額 3.129億美元
複合年成長率 15.2%

預計到2025年，單胃內球囊系統將佔據60.2%的市場。這主要歸功於其成熟的臨床應用、簡單的植入和取出流程，以及與多球囊系統相比更低的併發症風險。這些裝置因其植入過程簡單，可縮短手術時間並提高患者便利性而廣受歡迎。其簡便性使醫護人員能夠在確保安全標準的同時，更有效率地治療病患。因此，憑藉醫生們的大力支持和已證實的臨床療效，單球囊系統仍然是減重治療中最廣泛使用的選擇。

預計到2025年，生理食鹽水球囊市場規模將達到5,460萬美元，並在2035年之前以14.8%的複合年成長率成長。該細分市場因其高安全性和在體重管理治療中可靠的性能而廣受支持。即使發生洩漏或破裂，生理食鹽水球囊系統也能被人體安全吸收，進而最大限度地降低風險。這些球囊還能透過控制使用過程中的充氣量和提高穩定性來降低併發症的風險。其穩定的性能和高度的安全性使其成為尋求非手術減重方案的醫療保健專業人員和患者的信賴之選。

預計到2025年，北美胃內球囊市場將佔據38.9%的佔有率，這主要得益於該地區高肥胖率和對非侵入性體重管理方案日益成長的需求。久坐不動的生活方式和高熱量飲食等生活方式因素是導致全部區域肥胖率上升的重要原因。這加劇了肥胖相關疾病的負擔，並加速了早期療育策略的實施。該地區的醫療機構正擴大採用胃內球囊作為合格的患者接受減重手術的替代方案，推動了該市場在各種臨床環境中的穩定擴張。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性協議
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 肥胖症盛行率上升
      • 人們越來越傾向微創手術
      • 胃內球囊系統的技術進步
    • 產業潛在風險與挑戰
      • 副作用和併發症的風險
    • 市場機遇
      • 開發先進的口服可吞嚥球囊技術
      • 肥胖症治療與內視鏡治療中心擴建
  • 成長潛力分析
  • 監理情勢（基於初步調查）
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 還款方案（基於初步調查）
  • 未來市場趨勢
  • 波特五力分析
  • PESTEL 分析
  • 客戶洞察（基於初步研究）
  • 創業情境（基於初步研究）
  • 人工智慧的影響及其未來前景
  • 價值鏈分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析（基於初步研究）
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

  • 單胃內球囊
  • 雙胃內球囊
  • 三聯胃內球囊

第6章 市場估價與預測：依填充材分類，2022-2035年

  • 充滿生理食鹽水的氣球
  • 充氣氣球

第7章 市場估計與預測：依給藥途徑分類，2022-2035年

  • 內視鏡
  • 膠囊

第8章 市場估算與預測：依最終用途分類，2022-2035年

  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他最終用戶

第9章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Allurion
  • Beijing ZKSK Technology
  • Boston Scientific
  • Districlass Medical
  • Endalis
  • HEALTH WARE
  • Helioscopie
  • Medicone
  • Medispar
  • ReShape Lifesciences
  • SHENYUN
  • SILIMED
  • SPATZ
  • Suzhou Shenyun Medical
簡介目錄
Product Code: 1173

The Global Intragastric Balloon Market was valued at USD 77.5 million in 2025 and is estimated to grow at a CAGR of 15.2% to reach USD 312.9 million by 2035.

Intragastric Balloon Market - IMG1

The market growth is supported by rising obesity prevalence, improved clinical awareness, expanding access to weight management treatments, and increasing insurance coverage for obesity-related interventions. Continuous advancements in medical device technology are also improving treatment outcomes and patient acceptance. Intragastric balloons are minimally invasive, non-surgical weight-loss devices placed in the stomach to reduce food intake by creating a feeling of fullness. They are generally recommended for individuals who have not achieved results through diet and exercise alone. These devices are inserted endoscopically or in capsule form and removed after a defined treatment period. Ongoing innovation in balloon design, including adjustable systems and swallowable capsule technologies, is enhancing safety, comfort, and procedural efficiency. Integration of digital health tools and remote patient monitoring is further improving post-procedure care and treatment adherence. Expansion of specialized obesity management clinics is also supporting broader adoption across healthcare systems.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$ 77.5 Million
Forecast Value$312.9 Million
CAGR15.2%

The single intragastric balloon segment held a 60.2% share in 2025 owing to its established clinical usage, easier insertion and removal process, and lower complication risk compared to multi-balloon systems. These devices are widely preferred because they offer a straightforward implantation procedure that reduces procedural time and enhances patient convenience. Their simplicity also allows healthcare providers to perform treatments more efficiently while maintaining safety standards. As a result, single balloon systems continue to be the most widely used option in weight-loss interventions, supported by strong physician preference and proven clinical outcomes.

The saline-filled balloon segment generated USD 54.6 million in 2025 and is projected to grow at a CAGR of 14.8% through 2035. This segment is widely preferred due to its strong safety profile and reliable performance in weight management treatments. In case of leakage or rupture, saline-filled systems pose minimal risk as the solution is safely absorbed by the body. These balloons also provide controlled inflation and greater stability during use, reducing the likelihood of deflation-related complications. Their consistent performance and improved safety characteristics make them a trusted choice among healthcare professionals and patients seeking non-surgical weight loss solutions.

North America Intragastric Balloon Market held a 38.9% share in 2025, driven by a high prevalence of obesity and increasing demand for non-invasive weight management solutions. Lifestyle factors such as sedentary behavior and high-calorie diets have significantly contributed to rising obesity rates across the region. This has increased the burden of obesity-related conditions, encouraging early intervention strategies. Healthcare providers in the region are increasingly adopting intragastric balloons as an alternative to bariatric surgery for eligible patients, supporting steady market expansion across clinical settings.

Major players operating in the Global Intragastric Balloon Industry are Allurion, Boston Scientific, ReShape Lifesciences, SPATZ, Medispar, SILIMED, Endalis, HELIOSCOPIE, Districlass Medical, Beijing ZKSK Technology, SHENYUN, Suzhou Shenyun Medical, Medicone, HEALTH WARE. Companies in the Intragastric Balloon Market are focusing on strengthening their market position through continuous product innovation and the development of safer, more comfortable, and minimally invasive weight-loss devices. Strategic partnerships with hospitals, bariatric clinics, and healthcare providers are being used to expand clinical adoption and improve patient access. Firms are investing heavily in research and development to introduce adjustable and swallowable balloon technologies that enhance treatment efficiency and reduce procedural complexity. Expansion into emerging healthcare markets is also supporting revenue growth and broader geographic reach. In addition, companies are integrating digital health platforms and remote monitoring tools to improve patient follow-up and treatment outcomes. Strong emphasis is being placed on clinical trials and regulatory approvals to build trust and strengthen product credibility.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Filling material trends
    • 2.2.4 Administration trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of obesity
      • 3.2.1.2 Growing preference for minimally invasive procedures
      • 3.2.1.3 Technological advancements in intragastric balloon systems
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Risk of side effects and complications
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of advanced and swallowable balloon technologies
      • 3.2.3.2 Expansion of bariatric and endoscopic treatment centers
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario (Driven by primary research)
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Customer insights (Driven by primary research)
  • 3.11 Start-up scenarios (Driven by primary research)
  • 3.12 Impact of AI and its future assessment
  • 3.13 Value chain analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis (Driven by primary research)
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Single intragastric balloon
  • 5.3 Dual intragastric balloon
  • 5.4 Triple intragastric balloon

Chapter 6 Market Estimates and Forecast, By Filling Material, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Saline-filled balloon
  • 6.3 Gas-filled balloon

Chapter 7 Market Estimates and Forecast, By Administration, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Endoscopy
  • 7.3 Pill form

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Specialty clinics
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Allurion
  • 10.2 Beijing ZKSK Technology
  • 10.3 Boston Scientific
  • 10.4 Districlass Medical
  • 10.5 Endalis
  • 10.6 HEALTH WARE
  • 10.7 Helioscopie
  • 10.8 Medicone
  • 10.9 Medispar
  • 10.10 ReShape Lifesciences
  • 10.11 SHENYUN
  • 10.12 SILIMED
  • 10.13 SPATZ
  • 10.14 Suzhou Shenyun Medical